Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3523224012 | Product containing betamethasone and fusidic acid (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3713524013 | Betamethasone- and fusidic acid-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Betamethasone- and fusidic acid-containing product | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
| Betamethasone- and fusidic acid-containing product | Is a | Betamethasone in topical dosage form | false | Inferred relationship | Some | ||
| Betamethasone- and fusidic acid-containing product | Has active ingredient | Betamethasone | true | Inferred relationship | Some | 1 | |
| Betamethasone- and fusidic acid-containing product | Has active ingredient | Adrenal hormone | false | Inferred relationship | Some | ||
| Betamethasone- and fusidic acid-containing product | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
| Betamethasone- and fusidic acid-containing product | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Some | ||
| Betamethasone- and fusidic acid-containing product | Is a | Fusidic acid-containing product | false | Inferred relationship | Some | ||
| Betamethasone- and fusidic acid-containing product | Has active ingredient | Fusidate | true | Inferred relationship | Some | 2 | |
| Betamethasone- and fusidic acid-containing product | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
| Betamethasone- and fusidic acid-containing product | Is a | Fusidic acid in topical dosage form | false | Inferred relationship | Some | ||
| Betamethasone- and fusidic acid-containing product | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Betamethasone- and fusidic acid-containing product | Is a | Betamethasone-containing product | true | Inferred relationship | Some | ||
| Betamethasone- and fusidic acid-containing product | Is a | Fusidic acid-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Betamethasone- and fusidic acid-containing product in cutaneous dose form | Is a | True | Betamethasone- and fusidic acid-containing product | Inferred relationship | Some | |
| Betamethasone and fusidic acid only product | Is a | True | Betamethasone- and fusidic acid-containing product | Inferred relationship | Some | |
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | Is a | False | Betamethasone- and fusidic acid-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR